Both in Pharmaceuticals
TransCode Therapeutics vs Filana Therapeutics
Over the past year RNAZ returned +3.0% and FLNA returned −15.8%; their daily moves had a correlation of 0.08.
RNAZ +3.0% FLNA −15.8%Growth of $1, one year, split-adjusted
| Metric | RNAZ | FLNA |
|---|---|---|
| Price | $1.74 | $0.6507 |
| Market cap | $29.5M | $31.4M |
| Today | +4.19% | +0.37% |
| 1 month | +6.7% | −29.6% |
| 6 months | −79.3% | — |
| Year to date | −74.5% | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.7M | $82.7M |
| Dividend yield | — | — |
| Volatility (60d) | 76.2% | — |
| Short % of float | 8.1% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).